[ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#Head", "@graph": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#pubinfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#pubinfo", "@graph": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "Y/yewUXixCTaxJ6eTOT7HdMWN6+gHHvr53TAC1h0fiqtqQ+k9nFOlzHIBdCBkF/HvvrEPNHB2T9bofv9xgjs7avGsEGILEPN5lt94ZF4TvWO1je+lbuPfRxa9aDXlxBZMi1qFfTWuhzHNoPq06PWugjhjttCqrPaej2+D5zvfjM=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg" } ] }, { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg", "http://purl.org/dc/terms/created": [ { "@value": "2021-04-12T10:05:40.258+02:00", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://purl.org/dc/terms/creator": [ { "@id": "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate": [ { "@id": "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate": [ { "@id": "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RA56KBJXCfPObqVb3hNCSbbohzz02_VEW2PxnmyIQ0Hus" } ] } ] }, { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#provenance", "@graph": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#assertion", "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-1468-3557" } ] } ] }, { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#assertion", "@graph": [ { "@id": "http://purl.bioontology.org/ontology/MEDDRA/10021750", "https://schema.org/possibleTreatment": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#medtherapy" } ] }, { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#medtherapy", "http://www.w3.org/ns/prov#wasDerivedFrom": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#quote" } ], "https://schema.org/drug": [ { "@id": "http://identifiers.org/drugbank/DB01080" } ], "https://schema.org/targetPopulation": [ { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#targetpop" } ], "https://w3id.org/neurodkg/indicationType": [ { "@id": "https://w3id.org/neurodkg/SymptomaticReliefIndication" } ] }, { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#quote", "http://www.w3.org/ns/prov#value": [ { "@value": "Vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss" } ], "http://www.w3.org/ns/prov#wasQuotedFrom": [ { "@id": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b8fb137-848b-45fd-9107-a6db5a675360" } ] }, { "@id": "http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#targetpop", "https://schema.org/audienceType": [ { "@value": "pediatric patients with infantile spasms 1 month to 2 years of age" } ], "https://schema.org/requiredMaxAge": [ { "@value": "2" } ], "https://schema.org/requiredMinAge": [ { "@value": "0" } ] } ] } ]